iBio, Inc. (IBIO) Financials

IBIO Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 34.0 million 24.8 million
2023-09-30 37.7 million 24.5 million
2023-06-30 41.2 million 25.8 million
2023-03-31 44.4 million 27.0 million

IBIO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -4.7 million 456000
2023-09-30 -5.3 million 765000
2023-06-30 -5.5 million 446000
2023-03-31 -3.7 million 1.6 million

IBIO Net Income

No data available :(

IBIO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 2.8 million - 3.8 million
2023-09-30 1.5 million - 4.0 million
2023-06-30 4.3 million - 4.1 million
2023-03-31 6.6 million - 4.3 million

IBIO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 1.9 million
2023-09-30 24.0 million
2023-06-30 17.2 million
2023-03-31 13.2 million

IBIO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 1.5 million 3.0 million -
2023-09-30 - 1.6 million 3.5 million -
2023-06-30 506000 2.4 million 2.6 million -
2023-03-31 201000 2.6 million 3.5 million -

IBIO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 387000
2023-09-30 50000 250000
2023-06-30 - 31000
2023-03-31 - 282000

IBIO

Price: $1.76

52 week price:
1.02
28.20

Earnings Per Share: -15.25 USD

P/E Ratio: -0.03

Exchange: ASE

Sector: Healthcare

Industry: Biotechnology

Volume: 1.7 million

Market Capitalization: 7.2 million

Links: